MicroRNA-21 inhibits p57Kip2 expression in prostate cancer

Sweta Mishra, Chun-Lin Lin, Tim H-M Huang

  • 1Department of Cellular and Structural Biology, University of Texas Health Science Center, 7703 Floyd Curl Drive, Mail Code 7762, San Antonio, TX 78229-3900, USA. sunl@uthscsa.edu.

Molecular Cancer
|September 14, 2014
PubMed
Abstract

Insights

MicroRNA-21 (miR-21) downregulates the tumor suppressor p57(Kip2) in prostate cancer by targeting its coding region. This interaction reveals a new mechanism for cancer development and a novel oncogenic role for miR-21.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • p57(Kip2) is a cyclin-dependent kinase inhibitor and a potential tumor suppressor.
  • Decreased p57(Kip2) expression is common in various cancers, including prostate cancer.
  • Mutations in p57(Kip2) are rare, suggesting other regulatory mechanisms are involved.

Purpose of the Study:

  • To investigate the molecular mechanisms behind p57(Kip2) downregulation in prostate cancer.
  • To determine the role of microRNA-21 (miR-21) in regulating p57(Kip2) expression.

Main Methods:

  • Correlation analysis between p57(Kip2) and miR-21 expression in prostate cancer samples.
  • In vitro studies using prostate cancer cells to assess miR-21 targeting of p57(Kip2).
  • Experiments involving anti-miR-21 inhibitors and p57(Kip2) knockdown.

Main Results:

  • A significant negative correlation was observed between p57(Kip2) and miR-21 expression.
  • miR-21 directly targets the coding region of p57(Kip2), reducing its mRNA and protein levels.
  • Inhibition of miR-21 increased p57(Kip2) expression and reversed effects on cell migration and growth.

Conclusions:

  • miR-21 downregulates p57(Kip2) expression and its functional responses in prostate cancer.
  • p57(Kip2) is identified as a novel target of miR-21 in prostate cancer.
  • This study reveals a new oncogenic function for miR-21 in prostate cancer development.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.8K
MicroRNAs01:22

MicroRNAs

9.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K